<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>2020 (2) TMI 220 - DELHI HIGH COURT</title>
    <link>https://www.taxtmi.com/caselaws?id=391776</link>
    <description>Prima facie illegal sale and supply of codeine-based syrup, Tramadol and Pentazocine can attract the NDPS bail embargo where the record does not satisfy the Section 37 threshold of reasonable grounds to believe the accused is not guilty. The material, including seizure evidence, Section 67 statements, call detail records and bank records, was treated as indicating supply to co-accused, and the alleged absence of bills and mandatory records under Rule 65 of the Drugs and Cosmetics Rules was viewed as supporting contravention of the NDPS regime. The commentary also notes that the NDPS Act operates in addition to the Drugs and Cosmetics framework, and that an unproved therapeutic-use defence does not displace the bail restriction.</description>
    <language>en-us</language>
    <pubDate>Tue, 28 Jan 2020 00:00:00 +0530</pubDate>
    <lastBuildDate>Fri, 07 Feb 2020 09:45:28 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=603076" rel="self" type="application/rss+xml"/>
    <item>
      <title>2020 (2) TMI 220 - DELHI HIGH COURT</title>
      <link>https://www.taxtmi.com/caselaws?id=391776</link>
      <description>Prima facie illegal sale and supply of codeine-based syrup, Tramadol and Pentazocine can attract the NDPS bail embargo where the record does not satisfy the Section 37 threshold of reasonable grounds to believe the accused is not guilty. The material, including seizure evidence, Section 67 statements, call detail records and bank records, was treated as indicating supply to co-accused, and the alleged absence of bills and mandatory records under Rule 65 of the Drugs and Cosmetics Rules was viewed as supporting contravention of the NDPS regime. The commentary also notes that the NDPS Act operates in addition to the Drugs and Cosmetics framework, and that an unproved therapeutic-use defence does not displace the bail restriction.</description>
      <category>Case-Laws</category>
      <law>Indian Laws</law>
      <pubDate>Tue, 28 Jan 2020 00:00:00 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/caselaws?id=391776</guid>
    </item>
  </channel>
</rss>